A novel azide-free asymmetric synthesis of oseltamivir phosphate (Tamiflu) starting from Roche's epoxide

被引:18
作者
Nie, Liang-Deng [1 ]
Wang, Fei-Feng [1 ]
Ding, Wei [1 ]
Shi, Xiao-Xin [1 ]
Lu, Xia [1 ]
机构
[1] E China Univ Sci & Technol, Sch Pharm, Dept Pharmaceut Engn, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
NEURAMINIDASE INHIBITOR OSELTAMIVIR; POTENT ANTIINFLUENZA ACTIVITY; RING-CLOSING METATHESIS; HIGH-YIELDING SYNTHESIS; ACID ETHYL-ESTER; SHIKIMIC ACID; (-)-SHIKIMIC ACID; CHEMOENZYMATIC SYNTHESIS; EFFICIENT SYNTHESIS; CONCISE SYNTHESIS;
D O I
10.1016/j.tetasy.2013.04.016
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
A novel azide-free asymmetric synthesis of oseltamivir phosphate 1 (Tamiflu (R)) starting from Roche's epoxide is described. Roche epoxide 2 was converted into N-acetyl aminoalcohol 3 in 95% yield via a BF3 center dot OEt2-catalyzed epoxide-opening with acetonitrile as a nucleophile. Compound 3 was then transformed into a methanesulfonate 4 in 98% yield. Compound 4 was converted into aziridine 5 in 91% yield. Aziridine 5 was subsequently converted into oseltamivir phosphate 1 via two paths (a and b). In the path a, compound 5 underwent aziridine-opening with diallylamine as a nucleophile to afford compound 7 in 93% yield; compound 7 could then be converted into oseltamivir phosphate 1 in 88% yield. In path b, compound 5 underwent aziridine-opening with isopropyl 2,2,2-trichloroacetimidate as a nucleophile to afford compound 8 in 94% yield, which was then converted into oseltamivir phosphate 1 in 82% yield. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:638 / 642
页数:5
相关论文
共 75 条
  • [1] What's in the medicine cabinet?
    Abbott, A
    [J]. NATURE, 2005, 435 (7041) : 407 - 409
  • [2] The synthetic development of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu®):: A challenge for synthesis & process research
    Abrecht, S
    Harrington, P
    Iding, H
    Karpf, M
    Trussardi, R
    Wirz, B
    Zutter, U
    [J]. CHIMIA, 2004, 58 (09) : 621 - 629
  • [3] The synthetic-technical development of oseltamivir phosphate tamiflu™:: A race against time
    Abrecht, Stefan
    Federspiel, Muriel Cordon
    Estermann, Heinrich
    Fischer, Rolf
    Karpf, Martin
    Mair, Hans-Juergen
    Oberhauser, Thomas
    Rimmler, Goesta
    Trussardi, Rene
    Zutter, Ulrich
    [J]. CHIMIA, 2007, 61 (03) : 93 - 99
  • [4] Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
    Bloom, Jesse D.
    Gong, Lizhi Ian
    Baltimore, David
    [J]. SCIENCE, 2010, 328 (5983) : 1272 - 1275
  • [5] New synthesis route avoids scarce starting materials - Fresh approach to Tamiflu production
    Burton, Nicola
    [J]. CHEMISTRY WORLD, 2007, 4 (07): : 30 - 30
  • [6] Streamlined process for the esterification and ketalization of shikimic acid en route to the key precursor for oseltamivir phosphate (Tamiflu™)
    Carr, Robert
    Ciccone, Frank
    Gabel, Richard
    Guinn, Martin
    Johnston, David
    Mastriona, Jill
    Vandermeer, Trevor
    Groaning, Michael
    [J]. GREEN CHEMISTRY, 2008, 10 (07) : 743 - 745
  • [7] Ring-closing metathesis-based synthesis of (3R,4R,5S)-4-acetylamino-5-amino-3-hydroxycyclohex-1-ene-carboxylic acid ethyl ester: A functionalized cycloalkene skeleton of GS4104
    Cong, Xin
    Yao, Zhu-Jun
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (14) : 5365 - 5368
  • [8] Shikimic acid and quinic acid: Replacing isolation from plant sources with recombinant microbial biocatalysis
    Draths, KM
    Knop, DR
    Frost, JW
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (07) : 1603 - 1604
  • [9] Liquidambar styraciflua:: a renewable source of shikimic acid
    Enrich, Liza B.
    Scheuermann, Margaret L.
    Mohadjer, Ashley
    Matthias, Kathryn R.
    Eller, Chrystal F.
    Newman, M. Scott
    Fujinaka, Michael
    Poon, Thomas
    [J]. TETRAHEDRON LETTERS, 2008, 49 (16) : 2503 - 2505
  • [10] Tamiflu: The supply problem
    Farina, Vittorio
    Brown, Jack D.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (44) : 7330 - 7334